Search Results - A/ T. Teplyakov

Refine Results
  1. 1
    INDUSTRIAL POLICY AND “NEW NORMALITY”

    INDUSTRIAL POLICY AND “NEW NORMALITY” by N. M. Abdikeev, A. Yu. Teplyakov

    Published 2017-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    TOWARD THE QUESTION OF ISCHEMIC MYOCARDIAL DYSFUNCTION

    TOWARD THE QUESTION OF ISCHEMIC MYOCARDIAL DYSFUNCTION by V. V. Kalyuzhin, A. T. Teplyakov, I. D. Bespalova, Ye. V. Kalyuzhina

    Published 2014-12-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Estimation of blood supply of the sternum after operations on the chest wall

    Estimation of blood supply of the sternum after operations on the chest wall by S. E. Mamchur, V. I. Chernov, A. T. Teplyakov, Yu. Yu. Vechersky, N. G. Krivonogov

    Published 2002-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-VESSEL LESION CORONARY ATHEROSCLEROSIS

    LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-... by M. N. Sin’kova, T. V. Pepelyaeva, L. K. Isakov, N. I. Tarasov, A. T. Teplyakov

    Published 2014-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Pathogenesis of chronic heart failure: change of dominating paradigm

    Pathogenesis of chronic heart failure: change of dominating paradigm by V. V. Kalyuzhin, A. T. Teplyakov, Yu. Yu. Vechersky, N. V. Ryazantsevа, A. P. Khlapov

    Published 2007-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction

    Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction by E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin

    Published 2022-04-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION

    EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION by A. T. Teplyakov, E. V. Grakova, E. N. Berezikova, S. N. Shilov, K. V. Kopeva, V. V. Kalyuzhin

    Published 2016-03-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction

    Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction by A. T. Teplyakov, D. Yu. Kamaev, V. V. Kalyuzhin, Ye. Yu. Pushnikova, Ye. V. Kalyuzhina, T. A. Stepacheva

    Published 2006-03-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Cardiology Research Institute, Tomsk National Research Medical Center

    Cardiology Research Institute, Tomsk National Research Medical Center by E. V. Grakova, K. V. Kopyeva, A. T. Teplyakov, L. K. Isakov, M. N. Sinkova, N. I. Tarasov

    Published 2022-08-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE

    NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE by N. I. Tarasov, M. N. Sinkova, L. K. Isakov, N. B. Lebedeva, V. A. Shilov, A. T. Teplyakov

    Published 2016-06-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    REMODELING OF THE LEFT VENTRICLE: ONE OR SEVERAL SCENARIOS?

    REMODELING OF THE LEFT VENTRICLE: ONE OR SEVERAL SCENARIOS? by V. V. Kalyuzhin, A. T. Teplyakov, M. A. Solovtsov, E. V. Kalyuzhina, I. D. Bespalova, N. N. Terentyeva

    Published 2016-10-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Prognostic role of neutrophil gelatinase-associated lipocalin in patients with coronary artery disease and abdominal obesity

    Prognostic role of neutrophil gelatinase-associated lipocalin in patients with coronary artery disease and abdominal obesity by A. V. Svarovskaya, P. A. Astanin, A/ T. Teplyakov, A. D. Vende, O. N. Ogurkova, A. A. Garganeeva

    Published 2023-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization

    Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocar... by E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko

    Published 2018-10-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction

    Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction by E. V. Grakova, K. V. Kopeva, S. N. Shilov, E. T. Bobyleva, E. N. Berezikova, V. V. Kalyuzhin, A. T. Teplyakov

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    FGB, TNFα, IL-1β, LPL, ITGB3, and TGFB1 genes polymorphism in patients with recurrent myocardial infarction

    FGB, TNFα, IL-1β, LPL, ITGB3, and TGFB1 genes polymorphism in patients with recurrent myocardial infarction by S. D. Mayanskaya, L. A. Garaeva, A. T. Teplyakov, M. L. Filipenko, E. A. Sokolova, O. A. Kravtsova, E. V. Berezikova

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Characteristics of left ventricular and cardiac hemodynamic remodeling after on-pump or off-pump coronary artery bypass grafting

    Characteristics of left ventricular and cardiac hemodynamic remodeling after on-pump or off-pump coronary artery bypass grafting by S. D. Mayanskaya, G. F. Abzalova, L. A. Garaeva, I. V. Abdulianov, A. T. Teplyakov, E. N. Berezikova, I. A. Grebenkina

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

    LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? by A. T. Teplyakov, A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, V. V. Kalyuzhin

    Published 2015-04-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy

    The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy by A. T. Teplyakov, S. N. Shilov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, K. V. Kopeva

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability

    Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability by E. V. Grakova, K. V. Kopeva, A. M. Gusakova, A. V. Smorgon, Sh. D. Akhmedov, V. V. Kalyuzhin, A. T. Teplyakov

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome

    Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome by A. T. Teplyakov, A. V. Yakovlev, S. N. Shilov, N. F. Yakovleva, E. N. Berezikova, E. V. Grakova, K. V. Kopeva, S. D. Mayanskaya

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: